Edition:
United States

People: Biogen Inc (BIIB.O)

BIIB.O on Nasdaq

289.93USD
29 Jul 2016
Change (% chg)

$0.90 (+0.31%)
Prev Close
$289.03
Open
$288.85
Day's High
$290.46
Day's Low
$286.80
Volume
1,338,487
Avg. Vol
1,835,852
52-wk High
$338.51
52-wk Low
$223.02

Koppel, Adam 

Dr. Adam M. Koppel, M.D. Ph.D. is Executive Vice President - Strategy and Business Development of the Company . He was Senior Vice President and Chief Strategy Officer of the Company . Dr. Koppel has served as our Executive Vice President, Strategy and Business Development since November 2015. Prior to that, Dr. Koppel served as our Senior Vice President and Chief Strategy Officer from May 2014 to October 2015, responsible for leading corporate strategy and portfolio management. Prior to joining us, Dr. Koppel served as a Managing Director of Brookside Capital, the public-equity affiliate of Bain Capital, since November 2003. Prior to Brookside Capital, he served as Associate Principal with McKinsey & Company, where he consulted to companies in the pharmaceutical and biotechnology industries. He received his B.A. degree in Harvard University, M.B.A. from Wharton School of the University of Pennsylvania , M.D. and Ph.D. from University of Pennsylvania School of Medicine.

Basic Compensation

Total Annual Compensation, USD 2,586,360
Restricted Stock Awards, USD 4,109,420
Long-Term Incentive Plans, USD --
All Other, USD 16,810
Fiscal Year Total, USD 6,712,600

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --